• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 16S rRNA 基因测序的结直肠腺瘤-癌序列中肠道微生物组的改变:系统评价和荟萃分析。

Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: A systematic review and meta-analysis.

机构信息

The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.

Department of Geriatrics, Hangzhou Red Cross Hospital, Hangzhou, China.

出版信息

Microb Pathog. 2024 Oct;195:106889. doi: 10.1016/j.micpath.2024.106889. Epub 2024 Aug 26.

DOI:10.1016/j.micpath.2024.106889
PMID:39197689
Abstract

BACKGROUND

Most sporadic colorectal cancers (CRC) develop through the adenoma-carcinoma sequence. While dysbiosis of the intestinal flora contributes to CRC's pathogenesis, precise microbial taxa closely associated with the colorectal adenoma-carcinoma sequence remain elusive. This meta-analysis aimed to summarize the features of intestinal flora in patients with AD and CRC.

METHODS

PubMed, Embase, Cochrane Library, and Web of Science were searched for case-control studies comparing the relative abundance of gut microbiota in the feces of patients with AD, CRC, and healthy controls (HC) from inception to January 2024. The weighted mean difference (WMD) with a 95 % confidence interval (CI) was used to display the results. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of the entailed literature. Publication bias was evaluated with the Egger's and Begg's tests.

RESULTS

Eleven studies were included, involving 477 CRC patients, 628 AD patients, and 864 healthy controls. Compared with HC, the patients with AD had a significantly lower Chao 1 index (WMD = -30.17, 95 % CI [-41.10, -19.23], P < 0.001) and Shannon index (WMD = -0.11 95 % CI [-0.18, -0.04], P = 0.002). Compared with AD, the CRC patients had a significantly higher Chao1 index (WMD = 22.09, 95 % CI [7.59, 36.00], P = 0.003) and Shannon index (WMD = 0.08, 95 % CI [0.00, 0.15], P = 0.037). Enterobacteriaceae (WMD = 0.03 95 % CI [0.00,0.05], P = 0.047; WMD = 0.02 95 % CI [0.00,0.04], P = 0.027) significantly increased in the order of Control-AD-CRC, while that of Blautia (WMD = -0.00 95 % CI [-0.01, -0.00], P = 0.001; WMD = -0.00 95 % CI [-0.00, -0.00], P = 0.002) was reduced. Compared with HC, the relative abundance of Proteobacteria (WMD = 0.05 95 % CI [0.03,0.07], P < 0.001), Fusobacteria (WMD = 0.02 95 % CI [0.00,0.03], P = 0.042), Streptococcaceae (WMD = 0.03 95 % CI [0.01,0.05], P = 0.017), Prevotellaceae (WMD = 0.02 95 % CI [0.00,0.04], P = 0.040), and Escherichia-Shigella (WMD = 0.06 95 % CI [0.01, 0.11], P = 0.021) was enriched in the CRC group. The relative abundance of Alistipes (WMD = 0.00 95 % CI [0.00,0.01], P = 0.032) and Streptococcus (WMD = 0.00 95 % CI [0.00,0.00], P = 0.001) was increased in the AD vs HC. The relative abundance of Firmicutes (WMD = -0.07 95 % CI [-0.12, -0.03], P = 0.003), Bifidobacteria (WMD = -0.03 95 % CI [-0.05, -0.01], P = 0.016), and Klebsiella (WMD = -0.01 95 % CI [-0.01, -0.00], P = 0.001) was decreased in the CRC vs HC. Compared with AD, the relative abundance of Firmicutes (WMD = -0.04 95 % CI [-0.07, -0.02], P = 0.002), Peptostreptococcaceae (WMD = -0.03 95 % CI [-0.05, -0.00], P = 0.021), Lachnospiraceae (WMD = -0.04 95 % CI [-0.08,-0.00], P = 0.037), Ruminococcaceae (WMD = -0.06 95 % CI [-0.09,-0.03], P < 0.001), Faecalibacterium (WMD = -0.01 95 % CI [-0.02, -0.01], P = 0.001), and Lachnoclostridium (WMD = -0.02 95 % CI [-0.03, -0.00], P = 0.040) was decreased in the CRC group, while Proteobacteria (WMD = 0.04 95 % CI [0.02,0.05], P < 0.001) was increased.

CONCLUSIONS

The dysbiosis characterized by reduced levels of short-chain fatty acid (SCFA)-producing bacteria, decreased anti-inflammatory bacteria, increased pro-inflammatory bacteria, and an elevation of bacteria with cytotoxic effects damaging to DNA may represent the specific microbial signature of colorectal adenoma/carcinoma. Further research is required to elucidate the mechanisms by which gut dysbiosis leads to the progression from AD to CRC and to explore the potential of specific microbiota markers in clinical treatment and non-invasive screening.

摘要

背景

大多数散发性结直肠癌(CRC)是通过腺瘤-癌序列发展而来的。虽然肠道菌群失调有助于 CRC 的发病机制,但与结直肠腺瘤-癌序列密切相关的确切微生物类群仍难以捉摸。本荟萃分析旨在总结 AD 和 CRC 患者肠道菌群的特征。

方法

从建库到 2024 年 1 月,通过 PubMed、Embase、Cochrane 图书馆和 Web of Science 搜索比较 AD、CRC 和健康对照(HC)患者粪便中肠道微生物群落相对丰度的病例对照研究。使用加权均数差(WMD)和 95%置信区间(CI)显示结果。使用纽卡斯尔-渥太华量表(NOS)评估纳入文献的质量。使用 Egger's 和 Begg's 检验评估发表偏倚。

结果

纳入 11 项研究,涉及 477 例 CRC 患者、628 例 AD 患者和 864 例健康对照。与 HC 相比,AD 患者的 Chao1 指数明显降低(WMD=-30.17,95%CI[-41.10,-19.23],P<0.001)和 Shannon 指数明显降低(WMD=-0.11,95%CI[-0.18,-0.04],P=0.002)。与 AD 相比,CRC 患者的 Chao1 指数明显升高(WMD=22.09,95%CI[7.59,36.00],P=0.003)和 Shannon 指数明显升高(WMD=0.08,95%CI[0.00,0.15],P=0.037)。肠杆菌科(WMD=0.03,95%CI[0.00,0.05],P=0.047;WMD=0.02,95%CI[0.00,0.04],P=0.027)在控制-AD-CRC 顺序中显著增加,而 Blautia(WMD=-0.00,95%CI[-0.01,-0.00],P=0.001;WMD=-0.00,95%CI[-0.00,-0.00],P=0.002)减少。与 HC 相比,厚壁菌门(WMD=0.05,95%CI[0.03,0.07],P<0.001)、梭杆菌门(WMD=0.02,95%CI[0.00,0.03],P=0.042)、链球菌科(WMD=0.03,95%CI[0.01,0.05],P=0.017)、普雷沃氏菌科(WMD=0.02,95%CI[0.00,0.04],P=0.040)和 Escherichia-Shigella(WMD=0.06,95%CI[0.01,0.11],P=0.021)的相对丰度增加。Alistipes(WMD=0.00,95%CI[0.00,0.01],P=0.032)和链球菌(WMD=0.00,95%CI[0.00,0.00],P=0.001)的相对丰度在 AD 与 HC 中增加。厚壁菌门(WMD=-0.07,95%CI[-0.12,-0.03],P=0.003)、双歧杆菌科(WMD=-0.03,95%CI[-0.05,-0.01],P=0.016)和克雷伯氏菌(WMD=-0.01,95%CI[-0.01,-0.00],P=0.001)的相对丰度在 CRC 与 HC 中降低。与 AD 相比,厚壁菌门(WMD=-0.04,95%CI[-0.07,-0.02],P=0.002)、消化链球菌科(WMD=-0.03,95%CI[-0.05,-0.00],P=0.021)、Lachnospiraceae(WMD=-0.04,95%CI[-0.08,-0.00],P=0.037)、瘤胃球菌科(WMD=-0.06,95%CI[-0.09,-0.03],P<0.001)、Faecalibacterium(WMD=-0.01,95%CI[-0.02,-0.01],P=0.001)和 Lachnoclostridium(WMD=-0.02,95%CI[-0.03,-0.00],P=0.040)的相对丰度降低,而变形菌门(WMD=0.04,95%CI[0.02,0.05],P<0.001)增加。

结论

以短链脂肪酸(SCFA)产生菌水平降低、抗炎菌减少、促炎菌增加和具有损伤 DNA 作用的细胞毒性菌升高为特征的肠道菌群失调可能代表结直肠腺瘤/癌的特定微生物特征。需要进一步研究肠道菌群失调如何导致 AD 发展为 CRC,以及探索特定微生物标志物在临床治疗和非侵入性筛查中的潜在应用。

相似文献

1
Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: A systematic review and meta-analysis.基于 16S rRNA 基因测序的结直肠腺瘤-癌序列中肠道微生物组的改变:系统评价和荟萃分析。
Microb Pathog. 2024 Oct;195:106889. doi: 10.1016/j.micpath.2024.106889. Epub 2024 Aug 26.
2
Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma.结直肠腺瘤/癌患者肠道菌群与临床特征的相关性分析。
Biomed Res Int. 2022 Jul 28;2022:3140070. doi: 10.1155/2022/3140070. eCollection 2022.
3
Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: A systematic review and meta-analysis.多囊卵巢综合征患者肠道微生物多样性和相对丰度的改变:系统评价和荟萃分析。
Microb Pathog. 2023 Nov;184:106370. doi: 10.1016/j.micpath.2023.106370. Epub 2023 Sep 21.
4
Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.使用 16SrRNA 测序研究微生物组与结直肠癌易感性的关系。
Biomed Res Int. 2020 Jan 30;2020:7828392. doi: 10.1155/2020/7828392. eCollection 2020.
5
Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.1,2-二甲基肼诱导的“腺瘤-癌序列”小鼠结直肠癌模型中肠道微生物群的进化生物学变化
Oncotarget. 2017 Jan 3;8(1):444-457. doi: 10.18632/oncotarget.13443.
6
Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.结直肠肿瘤发生过程中肠道微生物群和血浆炎症因子的变化:一项病例对照研究。
BMC Microbiol. 2018 Aug 29;18(1):92. doi: 10.1186/s12866-018-1232-6.
7
Distinct gut microbiomes in Thai patients with colorectal polyps.泰国结直肠息肉患者独特的肠道微生物群。
World J Gastroenterol. 2024 Jul 21;30(27):3336-3355. doi: 10.3748/wjg.v30.i27.3336.
8
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.结直肠腺瘤患者粪便代谢组学特征与肠道微生物群及结直肠癌发病早期事件相关。
mBio. 2020 Feb 18;11(1):e03186-19. doi: 10.1128/mBio.03186-19.
9
Changes in the gut microbiome of patients with esophageal cancer: A systematic review and meta-analysis based on 16S gene sequencing technology.食管癌患者肠道微生物组的变化:基于 16S 基因测序技术的系统评价和荟萃分析。
Microb Pathog. 2024 Aug;193:106784. doi: 10.1016/j.micpath.2024.106784. Epub 2024 Jul 4.
10
Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.非酒精性脂肪性肝病患者肠道微生物群的组成改变:一项系统评价和Meta分析。
Lipids Health Dis. 2021 Feb 26;20(1):22. doi: 10.1186/s12944-021-01440-w.

引用本文的文献

1
Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3.致瘤性病理共生大肠杆菌LI60C3的表型特征及全基因组分析
Gut Pathog. 2025 Aug 20;17(1):63. doi: 10.1186/s13099-025-00732-1.
2
Structural analysis and prebiotic properties of the polysaccharides produced by YT013.YT013产生的多糖的结构分析及益生元特性
Food Chem X. 2025 Jun 2;28:102600. doi: 10.1016/j.fochx.2025.102600. eCollection 2025 May.
3
The Knowledge Gap in Gut Microbiome Characterization in Early-Onset Colorectal Cancer Patients: A Systematic Scoping Review.
早发性结直肠癌患者肠道微生物群特征的知识差距:一项系统综述。
Cancers (Basel). 2025 May 31;17(11):1863. doi: 10.3390/cancers17111863.